Dr. Eric Christopher Kleerup, MD

Dr. Kleerup practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Kleerup's NPI, 1215956636, was assigned on July 18, 2006. Dr. Kleerup graduated from Washington University School of Medicine in 1988. Dr. Kleerup holds California license G68275.

Dr. Kleerup's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Kleerup's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Kleerup is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Kleerup to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kleerup practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kleerup's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Kleerup is licensed in California.

CMS data shows 622 Medicare services from Dr. Kleerup across 2 procedure codes in 2024, all of them office visits, for 242 Medicare patients. Medicare paid $46,423 for them.

CMS counts 242 Medicare patients who saw Dr. Kleerup in 2024. The largest group is 75 to 84, with 107 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 27% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kleerup's median patient age at 73, with 65% women.

In 2024, Dr. Kleerup wrote 1,729 Medicare Part D claims for 278 patients. CMS names the drug for 1,570 of them, across 39 drugs with 11 or more claims each, at $759,679 in total drug cost. In 2023, CMS named 1,777 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Kleerup for performance year 2024, reported as part of a group. Dr. Kleerup accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kleerup as offering telehealth.

Dmand AI links 46 papers to Dr. Kleerup, published from 2011 to 2019. 2018 was the busiest year, with 7. The most frequent topics are HIV Infections, Pulmonary Disease, Chronic Obstructive and Respiratory Function Tests. Dr. Kleerup has published most often in AIDS. Dr. Kleerup's most frequent co-authors are Eugene Bleecker, MD, Meilan King Han, MD and Stephen I. Rennard, MD.

Dmand AI links Dr. Kleerup to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Bronchitis, Chronic, Pulmonary Emphysema and Emphysema.

CMS Open Payments shows 18 general payments to Dr. Kleerup from 5 drug and device companies from 2017 to 2020. Consulting fees make up the largest share, 91% of the total. Merck Sharp & Dohme Corporation paid the most, $3,900.

Dr. Kleerup graduated from Washington University School of Medicine in 1988.